EDQM Offers Free Access to European Quality Standards for COVID-19 Vaccine Developers
The European Directorate for the Quality of Medicines and Healthcare (EDQM) has opened up access to the texts of the European Pharmacopoeia (Ph. Eur.) to support developers of COVID-19 vaccines.
The European Directorate for the Quality of Medicines and Healthcare (EDQM) has opened up access to the texts of the European Pharmacopoeia (Ph. Eur.) to support developers of COVID-19 vaccines.
EDQM revealed in a June 8, 2020 press release, that the selection of quality standards for vaccines, including those for viral vaccines, is available for free on a temporary basis online. The package of standards that are available will be regularly reviewed and updated.
Developers accessing the quality standards will be able to build in the appropriate analytical control strategies for the COVID-19 vaccines under development and ultimately ensure the quality and safety of final products. Additionally, application of the quality standards may aid in expediting regulatory acceptance of a marketing authorization application.
More detail is available on EDQM’s website.
Source: EDQM
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
